RXRX is currently covered by 3 analysts with an average price target of $6.5. This is a potential upside of $4.05 (165.31%) from yesterday's end of day stock price of $2.45.
Recursion Pharmaceuticals's activity chart (see below) currently has 94 price targets and 73 ratings on display. The stock rating distribution of RXRX is 60% BUY and 40% HOLD.
Analysts' price targets on this stock were met 56.54% of the time, taking 45 days on average.
Highest price target for RXRX is $8, Lowest price target is $5.5, average price target is $6.5.
Most recent stock forecast was given by GIL BLUM from NEEDHAM on 19-Oct-2026. First documented stock forecast 11-May-2021.
Currently out of the existing stock ratings of RXRX, 3 are a BUY (60%), 2 are a HOLD (40%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 16-Mar-2023
$8
$5.55 (226.53%)
$8
1 months 3 days ago
(19-Oct-2026)
2/29 (6.9%)
$4.39 (121.61%)
71
Hold Since 18-Aug-2025
$5.5
$3.05 (124.49%)
$5
6 months 8 days ago
(14-May-2026)
1/3 (33.33%)
$2.46 (80.92%)
2
Hold Since 26-Feb-2026
$6
$3.55 (144.90%)
$10
8 months 27 days ago
(26-Feb-2026)
2/3 (66.67%)
$2.23 (59.15%)
73
Hold Since 03-Sep-2024
$5
$8
1 years 4 months 19 days ago
(03-Jul-2025)
3/5 (60%)
$-0.27 (-5.12%)
65
Hold Since 25-Oct-2022
$6
$8
1 years 8 months 20 days ago
(02-Mar-2025)
6/8 (75%)
$-1.51 (-20.11%)
59
What is RXRX (Recursion Pharmaceuticals) average time for price targets to be met?
Which analyst most recently updated their price target on RXRX (Recursion Pharmaceuticals)?
Which analyst has the most public recommendations on RXRX (Recursion Pharmaceuticals)?
Which analyst is the currently most bullish on RXRX (Recursion Pharmaceuticals)?
Which analyst is the currently most reserved on RXRX (Recursion Pharmaceuticals)?